Investigation of pd-l1 (cd274), pd-l2 (pdcd1lg2), and ctla-4 expressions in malignant pleural mesothelioma by immunohistochemistry and real-time polymerase chain reaction methods.

Sule Kutlar Dursun, Fatma; Alabalik, Ulas

Sule Kutlar Dursun, Fatma; Alabalik, Ulas.

Affiliation

Sule Kutlar Dursun F; Department of Pathology, University of Health Sciences Gazi Yasargil Trainning and Research Hospital, Diyarbakir, Turkey.
Alabalik U; Pathology Department, Medical School, Dicle University, Diyarbakir, Turkey.

Pol J Pathol ; 73(2): 111-119, 2022.

Article in En | MEDLINE | ID: mdl-36172747

Subject(s)

Lung Neoplasms; Mesothelioma, Malignant; Mesothelioma; Pleural Neoplasms; Humans; B7-H1 Antigen/metabolism; Biomarkers, Tumor/analysis; Immunohistochemistry; Lung Neoplasms/metabolism; Mesothelioma/metabolism; Prognosis; Programmed Cell Death 1 Ligand 2 Protein/genetics; Real-Time Polymerase Chain Reaction

Key words

PD-L1 (CD274); PD-L2 (PDCD1LG2); immune checkpoints; malignant pleural mesothelioma; programmed cell death ligand 1; programmed cell death ligand 2; CTLA-4

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Mesothelioma, Malignant / Lung Neoplasms / Mesothelioma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Pol J Pathol Journal subject: PATOLOGIA Year: 2022 Type: Article Affiliation country: Turkey

Fulltext

XML

PubMed Links

Search on Google